There are 2867 resources available
1252P - Update results of anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase Ⅱ clinical trial
Presenter: Yan-Feng Zhang
Session: Poster session 16
1255P - da VINci: Safety and efficacy of the OTSGC-A24 vaccine and nivolumab in metastatic gastric cancer
Presenter: Joan Choo
Session: Poster session 17
1256P - Three courses of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective phase II clinical trial
Presenter: GUozhen Yang
Session: Poster session 17
1257P - Apatinib plus POF (paclitaxel plus FOLFOX) in patients (pts) with treatment-naïve advanced gastric cancer (TNAGC): Update from the phase I study (SYLT 007)
Presenter: Shen Zhao
Session: Poster session 17
1258P - HJM-353: A potent, selective and orally bioavailable EED inhibitor with robust anti-tumor activities
Presenter: Xin Ma
Session: Poster session 17
1261TiP - CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)
Presenter: Francis Esposito
Session: Poster session 17